| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 600276.CN | Jiangsu Hengrui Pharmaceuticals Co., Ltd | 63.5 | ¤52,550 | CN |
| 603259.CN | WuXi AppTec Co., Ltd. Class A | 70.8 | ¤27,262 | CN |
| 300015.CN | Aier Eye Hospital Group Co., Ltd. Class | 64.0 | ¤15,886 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 80.2 | ¤9,254 | CN |
| 000999.CN | China Resources Sanjiu Medical & Pharmac | 59.9 | ¤7,196 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 60.0 | ¤587 | CN |
| 688179.CN | Shanghai Aladdin Biochemical Technology | 62.3 | ¤590 | CN |
| 301277.CN | Newland Pharmaceutical Co., Ltd. Class A | 60.8 | ¤618 | CN |
| 688581.CN | Hangzhou AGS MedTech Co. Ltd. | 62.1 | ¤715 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 60.8 | ¤1,063 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 600276.CN | Jiangsu Hengrui Pharmaceuticals Co., Ltd | 63.5 | 22 | CN |
| 000999.CN | China Resources Sanjiu Medical & Pharmac | 59.9 | 19 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 80.2 | 19 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 69.5 | 18 | CN |
| 300015.CN | Aier Eye Hospital Group Co., Ltd. Class | 64.0 | 11 | CN |
| 600062.CN | China Resources Double-Crane Pharmaceuti | 70.9 | 11 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 60.8 | 10 | CN |
| 002262.CN | Jiangsu Nhwa Pharmaceutical Co., Ltd. Cl | 67.3 | 10 | CN |
| 600216.CN | Zhejiang Medicine Co., Ltd. Class A | 62.9 | 9 | CN |
| 600750.CN | Jiangzhong Pharmaceutical Co., Ltd. Clas | 67.3 | 9 | CN |
| Average Market Cap | ¤5,730 |
| Median Market Cap | ¤2,012 |
| Avg. 3 Mo. Dollar Vol. | ¤51,966,308 |
| Avg. 3 Mo. Trading Vol. | 14,437,816 |
| Last Rebalance Date | 06/16/2025 |
| Companies Replaced | 17 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 21.2 |
| Forward P/E Ratio (12 Mo.) | 16.2 |
| Price/Book Ratio | 3.3 |
| Avg. Revenue Chg. - 3 Yr | 41.3% |
| Avg. Op. Income Chg. - 3 Yr. | 60.2% |
| Avg. EPS Growth - 3 Yr. | 17.2% |
| Avg. EPS Growth - 1 Yr. | 17.2% |
| Avg. Operating Margin | 24.1% |
| Avg. LT Debt to Total Capital | 2.6% |
| Avg. Return on Equity | 16.2% |
| Dividend Yield | 1.7% |
| China Health Care Index | 64.35 |
| China | 100.0% |
